shortagewatch

Home / Nervous system / Buprenorphine, Combinations

ATC N07BC51 · Drugs Used in Opioid Dependence

Buprenorphine, Combinations shortage

As of 2 Nov 2026, Buprenorphine, Combinations has a reported shortage in 4 of the 15 countries we track (Canada, Czechia, Norway, Sweden), covering 12 products from 3 companies.

Countries4/15
Products12packs or presentations
Companies30 listed
Short since16 Dec 202423 months ago
Earliest return31 Dec 2026company estimate
Main reasonNot stated

Timeline

CanadaCzechiaNorwaySweden
202520262027LIBROXAR 2MG/0,5MG 2MG/0,5MG SLG TBL NOB 28LIBROXAR 2MG/0,5MG 2MG/0,5MG SLG TBL NOB 28Suboxone 12 mg/3 mg sublingvalfilm, 28x1 stkSuboxone 12 mg/3 mg sublingvalfilm, 28x1 stk doseposeSuboxone 16 mg/4 mg sublingvaltablett, 28 stSuboxone 16 mg/4 mg sublingvaltablett, 28 stk blisterpakningSuboxone 2 mg/0,5 mg sublingvalfilm, 28x1 stSuboxone 2 mg/0,5 mg sublingvalfilm, 28x1 stk doseposeSuboxone 2 mg/0,5 mg sublingvaltablett, 28 sSuboxone 2 mg/0,5 mg sublingvaltablett, 28 stk blisterpakningSuboxone 8 mg/2 mg sublingvalfilm, 28x1 stk Suboxone 8 mg/2 mg sublingvalfilm, 28x1 stk doseposeSuboxone 16 mg/4 mg Blister, 28 tabletter (PSuboxone 16 mg/4 mg Blister, 28 tabletter (PD: Orifarm AB)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Indivior Europe5Indivior4Heaton K.S.1

Compared with similar medicines

ATC group N07BC · Drugs Used in Opioid Dependence
Buprenorphine4/15Buprenorphine, Combinations4/15Methadone4/15Levomethadone2/15

Affected products

CountryProductCompanySinceExpected backReason
CASUBOXONE (28) discontinuationINDIVIOR UK LIMITEDnot given28 Feb 2027Not stated
CASUBOXONE (28) discontinuationINDIVIOR UK LIMITEDnot given16 Feb 2027Not stated
CASUBOXONE (28) discontinuationINDIVIOR UK LIMITEDnot given11 Feb 2027Not stated
CASUBOXONE (28) discontinuationINDIVIOR UK LIMITEDnot given31 Dec 2026Not stated
CZLIBROXAR 2MG/0,5MG 2MG/0,5MG SLG TBL NOB 28Heaton k.s., Praha16 Dec 202431 Dec 2026Commercial decision or withdrawal
Obchodní/marketingové důvody
NOSuboxone 12 mg/3 mg sublingvalfilm, 28x1 stk doseposeIndivior Europe Limited19 Dec 202531 Dec 2026Commercial decision or withdrawal
Planlagt utfasing/avregistrering
NOSuboxone 16 mg/4 mg sublingvaltablett, 28 stk blisterpakningIndivior Europe Limited19 Dec 202531 Dec 2026Commercial decision or withdrawal
Planlagt utfasing/avregistrering
NOSuboxone 2 mg/0,5 mg sublingvalfilm, 28x1 stk doseposeIndivior Europe Limited19 Dec 202531 Dec 2026Commercial decision or withdrawal
Planlagt utfasing/avregistrering
NOSuboxone 2 mg/0,5 mg sublingvaltablett, 28 stk blisterpakningIndivior Europe Limited19 Dec 202531 Dec 2026Commercial decision or withdrawal
Planlagt utfasing/avregistrering
NOSuboxone 8 mg/2 mg sublingvalfilm, 28x1 stk doseposeIndivior Europe Limited19 Dec 202531 Dec 2026Commercial decision or withdrawal
Planlagt utfasing/avregistrering
SESuboxone 16 mg/4 mg Blister, 28 tabletter (PD: Orifarm AB)15 Dec 2025not givenNot stated
SEBuprenorphine/Naloxone Viatris 8 mg/2 mg Blister, 28 x 1 tabletter (endos) anticipated4 Jan 20274 Apr 2027Not stated

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.